Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

James B Bussel

Showing results (21-30 of 262) with videos related to

Pageof 27
Sort By:
American Journal of Hematology|November 17, 2006
Safety and tolerability of a novel chromatography-based intravenous immunoglobulin when administered at a high infusion rate in patients with immune thrombocytopenic purpuraJames B Bussel, Kim Hanna,
British Journal of Haematology|August 3, 2022
Should dexamethasone alone or in combination be the initial steroid for adult ITP: Still a relevant questionBarbara Skopec, James B Bussel
Current Rheumatology Reports|April 29, 2010
The long-term impact of rituximab for childhood immune thrombocytopeniaNichola Cooper, James B Bussel
Blood Reviews|November 6, 2007
Fetal and neonatal alloimmune thrombocytopenia: progress and ongoing debatesJames B Bussel, Andrea Primiani
The Lancet. Haematology|August 28, 2020
Preparing patients with immune thrombocytopenia for surgery: what are the options?James B Bussel, David Kuter
Clinical Lymphoma & Myeloma|May 27, 2008
Overview of thrombopoietic agents in the treatment of thrombocytopeniaRachel Kobos, James B Bussel
F1000Prime Reports|July 4, 2014
Management of thrombocytopeniaMarina Izak, James B Bussel
British Journal of Haematology|September 8, 2021
Heritable platelet disorders: an enigma even guidelines can't unravelJames B Bussel, Ellinor Peerschke
Current Opinion in Pediatrics|January 17, 2008
Diagnosis, pathophysiology and management of children with refractory immune thrombocytopenic purpuraRam Kalpatthi, James B Bussel
Hematology/Oncology Clinics of North America|August 2, 2007
Immune thrombocytopenic purpuraBethan Psaila, James B Bussel
Pageof 27

Showing results (21-30 of 262) with videos related to

Sort By:
Pageof 27
American Journal of Hematology|November 17, 2006
Safety and tolerability of a novel chromatography-based intravenous immunoglobulin when administered at a high infusion rate in patients with immune thrombocytopenic purpuraJames B Bussel, Kim Hanna,
British Journal of Haematology|August 3, 2022
Should dexamethasone alone or in combination be the initial steroid for adult ITP: Still a relevant questionBarbara Skopec, James B Bussel
Current Rheumatology Reports|April 29, 2010
The long-term impact of rituximab for childhood immune thrombocytopeniaNichola Cooper, James B Bussel
Blood Reviews|November 6, 2007
Fetal and neonatal alloimmune thrombocytopenia: progress and ongoing debatesJames B Bussel, Andrea Primiani
The Lancet. Haematology|August 28, 2020
Preparing patients with immune thrombocytopenia for surgery: what are the options?James B Bussel, David Kuter
Clinical Lymphoma & Myeloma|May 27, 2008
Overview of thrombopoietic agents in the treatment of thrombocytopeniaRachel Kobos, James B Bussel
F1000Prime Reports|July 4, 2014
Management of thrombocytopeniaMarina Izak, James B Bussel
British Journal of Haematology|September 8, 2021
Heritable platelet disorders: an enigma even guidelines can't unravelJames B Bussel, Ellinor Peerschke
Current Opinion in Pediatrics|January 17, 2008
Diagnosis, pathophysiology and management of children with refractory immune thrombocytopenic purpuraRam Kalpatthi, James B Bussel
Hematology/Oncology Clinics of North America|August 2, 2007
Immune thrombocytopenic purpuraBethan Psaila, James B Bussel
Pageof 27